MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) — BrandJet AI, a platform for multi-channel sales outreach and brand intelligence, today announced it has acquired IGLeads, a no-code lead generation tool used by thousands of businesses to collect publicly available contact data from Instagram, TikTok, LinkedIn, Facebook, Google Maps, and other sources. Terms of the deal were not disclosed.The acquisition joins two halves of a workflow that most sales teams currently run in separate tools. IGLeads customers will be able to send newly built lead lists straight into BrandJet’s outreach sequences, which cover email, LinkedIn, X, WhatsApp, Instagram, and Telegram. BrandJet customers gain access to IGLeads’ extraction engine alongside BrandJet’s contact database, which the company reports hold more than 700 million records, and...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree GOOCH & HOUSEGO PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

MUMBAI, India, Aug. 07, 2026 (GLOBE NEWSWIRE) — Lumina Datamatics, a global leader in content, retail support, and technology solutions, today announced the completion of its acquisition of TNQTech, a leading Chennai-based publishing technology company. This transaction marks a significant milestone in Lumina Datamatics’ organic and inorganic growth strategy and positions the combined organization among the world’s largest providers of scholarly publishing solutions. The announcement follows the signing of a definitive agreement in December 2024 to acquire an 80% controlling stake in TNQTech. With the acquisition of the remaining 20%, the transaction has now been completed, making TNQTech a 100% wholly owned subsidiary of Lumina Datamatics. The combined entity brings together Lumina Datamatics’ global scale, customer relationships,...

Transaction expected to strengthen TPC Group’s position in the petrochemical C4 value chain and support continued investment in its Gulf Coast operations HOUSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) — TPC Group today announced that it has entered into a definitive agreement to be acquired by ENEOS Holdings, Inc. In connection with the acquisition, ENEOS will acquire TPC Group’s petrochemical operations in Houston, Texas, along with terminal operations in Port Neches, Texas, and Lake Charles, Louisiana. The transaction is expected to further strengthen ENEOS Group’s competitiveness in the petrochemical C4 value chain by leveraging its operational expertise in the crude C4 business and expanding its U.S. operations. This aligns with ENEOS’s strategy of positioning its base and materials business as a core focus area and continuously enhancing...

LIMERICK, Ireland, Aug. 06, 2026 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), (“Kneat” or the “Company”), the global leader in digital validation and quality process automation, today announced that the Ontario Superior Court of Justice (Commercial List) has issued a final order approving the previously announced plan of arrangement (the “Proposed Transaction”) whereby an affiliate of Thoma Bravo, L.P. (“Thoma Bravo”) will acquire all of the outstanding common shares of the Company (the “Shares”), other than any rollover shares. Subject to the satisfaction or waiver, where permitted, of the remaining conditions to closing contained in the arrangement agreement entered into between the Company and the Purchaser dated June 8, 2026, it is anticipated that the Proposed Transaction will be completed by the parties on...

Lead program now in Phase 1 development CAMBRIDGE, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing small-molecule therapies in immunology. The acquisition strengthens Biogen’s growing immunology portfolio, adding multiple assets that have potential to treat immune-mediated conditions across a range of indications. The lead program entered Phase 1 development in July 2026. “We are excited about the potential of these immunology assets as we continue to strengthen and diversify our pipeline for long-term growth,” said Priya Singhal, M.D., M.P.H., Executive Vice President and Head of Development at Biogen. “With the lead program now in Phase 1, this acquisition highlights...